{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["2(2)"],"submitter":["Weaver DJ"],"funding":["University of Michigan"],"pubmed_abstract":["<h4>Rationale & objective</h4>The objective of the study was to estimate the prevalence of hypertension in patients with proteinuric kidney disease and evaluate blood pressure (BP) control.<h4>Study design</h4>Retrospective cohort study.<h4>Setting & participants</h4>Data from adults and children with proteinuric kidney disease enrolled in the multicenter Kidney Research Network Registry were used for this study.<h4>Exposure</h4>Proteinuric kidney disease.<h4>Outcomes</h4>Hypertension and BP control.<h4>Analytical approach</h4>Patients with white-coat hypertension were excluded. Patients were censored at end-stage kidney disease onset. Patients were defined as hypertensive either by hypertension diagnosis code, having 2 or more encounters with elevated BPs, or treatment with antihypertensi"],"journal":["Kidney medicine"],"pagination":["131-138"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7380443"],"repository":["biostudies-literature"],"pubmed_title":["Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease."],"pmcid":["PMC7380443"],"pubmed_authors":["Pesenson A","Weaver DJ","Oh GJ","Eikstadt R","Modes MM","Troost JP","Selewski DT","Attalla SE","Elliott M","Waldo A","Adler S","Massengill SF","Gipson DS","Kamil ES","Lafayette RA","Gipson P"],"additional_accession":[]},"is_claimable":false,"name":"Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease.","description":"<h4>Rationale & objective</h4>The objective of the study was to estimate the prevalence of hypertension in patients with proteinuric kidney disease and evaluate blood pressure (BP) control.<h4>Study design</h4>Retrospective cohort study.<h4>Setting & participants</h4>Data from adults and children with proteinuric kidney disease enrolled in the multicenter Kidney Research Network Registry were used for this study.<h4>Exposure</h4>Proteinuric kidney disease.<h4>Outcomes</h4>Hypertension and BP control.<h4>Analytical approach</h4>Patients with white-coat hypertension were excluded. Patients were censored at end-stage kidney disease onset. Patients were defined as hypertensive either by hypertension diagnosis code, having 2 or more encounters with elevated BPs, or treatment with antihypertensi","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Mar-Apr","modification":"2025-04-05T13:44:04.079Z","creation":"2025-04-05T13:44:04.079Z"},"accession":"S-EPMC7380443","cross_references":{"pubmed":["32734234"],"doi":["10.1016/j.xkme.2019.10.012"]}}